Literature DB >> 24843130

PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid.

Qiong Lu1, Guangwen Lu2, Jianxun Qi2, Han Wang1, Yifang Xuan3, Qihui Wang2, Yan Li2, Yanfang Zhang4, Chunfu Zheng5, Zheng Fan2, Jinghua Yan2, George F Gao6.   

Abstract

Paired immunoglobulin-like type 2 receptor α (PILRα) and β (PILRβ) belong to the PILR family and are related to innate immune regulation in various species. Despite their high sequence identity, PILRα and PILRβ are shown to have variant sialic acid (SA) binding avidities. To explore the molecular basis of this interaction, we solved the crystal structures of PILRα and PILRβ at resolutions of 1.6 Å and 2.2 Å, respectively. Both molecules adopt a typical siglec fold but use a hydrophobic bond to substitute the siglec-specific disulfide linkage for protein stabilization. We further used HSV-1 glycoprotein B (gB) as a representative molecule to study the PILR-SA interaction. Deploying site-directed mutagenesis, we demonstrated that three residues (Y2, R95, and W108) presented on the surface of PILRα form the SA binding site equivalent to those in siglecs but are arranged in a unique linear mode. PILRβ differs from PILRα in one of these three residues (L108), explaining its inability to engage gB. Mutation of L108 to tryptophan in PILRβ restored the gB-binding capacity. We further solved the structure of this PILRβ mutant complexed with SA, which reveals the atomic details mediating PILR/SA recognition. In comparison with the free PILR structures, amino acid Y2 oriented variantly in the complex structure, thereby disrupting the linear arrangement of PILR residues Y2, R95, and W108. In conclusion, our study provides significant implications for the PILR-SA interaction and paves the way for understanding PILR-related ligand binding.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24843130      PMCID: PMC4050567          DOI: 10.1073/pnas.1320716111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b.

Authors:  Helen Attrill; Akihiro Imamura; Ritu S Sharma; Makoto Kiso; Paul R Crocker; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2006-08-08       Impact factor: 5.157

2.  The Ig-like v-type domain of paired Ig-like type 2 receptor alpha is critical for herpes simplex virus type 1-mediated membrane fusion.

Authors:  Qing Fan; Richard Longnecker
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

3.  Neutrophil infiltration during inflammation is regulated by PILRα via modulation of integrin activation.

Authors:  Jing Wang; Ikuo Shiratori; Junji Uehori; Masahito Ikawa; Hisashi Arase
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

4.  O-glycosylation potential of lepidopteran insect cell lines.

Authors:  M Lopez; D Tetaert; S Juliant; M Gazon; M Cerutti; A Verbert; P Delannoy
Journal:  Biochim Biophys Acta       Date:  1999-03-14

5.  High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family.

Authors:  Magnus S Alphey; Helen Attrill; Paul R Crocker; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

6.  Crystal structure of glycoprotein B from herpes simplex virus 1.

Authors:  Ekaterina E Heldwein; Huan Lou; Florent C Bender; Gary H Cohen; Roselyn J Eisenberg; Stephen C Harrison
Journal:  Science       Date:  2006-07-14       Impact factor: 47.728

7.  PANP is a novel O-glycosylated PILRα ligand expressed in neural tissues.

Authors:  Amane Kogure; Ikuo Shiratori; Jing Wang; Lewis L Lanier; Hisashi Arase
Journal:  Biochem Biophys Res Commun       Date:  2011-01-15       Impact factor: 3.575

8.  Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin.

Authors:  Nathan R Zaccai; Katsumi Maenaka; Taeko Maenaka; Paul R Crocker; Reinhard Brossmer; Sørge Kelm; E Yvonne Jones
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

9.  Competition of cell adhesion and immune recognition: insights into the interaction between CRTAM and nectin-like 2.

Authors:  Shuijun Zhang; Guangwen Lu; Jianxun Qi; Yan Li; Zhiyang Zhang; Buchang Zhang; Zheng Fan; Jinghua Yan; George F Gao
Journal:  Structure       Date:  2013-07-18       Impact factor: 5.006

10.  The myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 production.

Authors:  Cristina M Tato; Barbara Joyce-Shaikh; Antara Banerjee; Yi Chen; Manjiri Sathe; Sarah E Ewald; Man-Ru Liu; Daniel Gorman; Terrill K McClanahan; Joseph H Phillips; Paul G Heyworth; Daniel J Cua
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

View more
  9 in total

1.  O-glycans direct selectin ligands to lipid rafts on leukocytes.

Authors:  Bojing Shao; Tadayuki Yago; Hendra Setiadi; Ying Wang; Padmaja Mehta-D'souza; Jianxin Fu; Paul R Crocker; William Rodgers; Lijun Xia; Rodger P McEver
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

2.  Structural and thermodynamic analyses reveal critical features of glycopeptide recognition by the human PILRα immune cell receptor.

Authors:  Atsushi Furukawa; Kosuke Kakita; Tomoki Yamada; Mikihiro Ishizuka; Jiro Sakamoto; Nanao Hatori; Naoyoshi Maeda; Fumina Ohsaka; Takashi Saitoh; Takao Nomura; Kimiko Kuroki; Hisanori Nambu; Hisashi Arase; Shigeki Matsunaga; Masahiro Anada; Toyoyuki Ose; Shunichi Hashimoto; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

3.  Expression of the Pseudorabies Virus gB Glycoprotein Triggers NK Cell Cytotoxicity and Increases Binding of the Activating NK Cell Receptor PILRβ.

Authors:  Steffi De Pelsmaeker; Evelien Dierick; Barbara Klupp; Thomas C Mettenleiter; Claudia Cantoni; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

4.  The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion.

Authors:  W Du; S Amarachintha; A Wilson; Q Pang
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

5.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.

Authors:  Celeste M Karch; Lubov A Ezerskiy; Sarah Bertelsen; Alison M Goate
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

Review 6.  The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.

Authors:  Benjamin A H Smith; Carolyn R Bertozzi
Journal:  Nat Rev Drug Discov       Date:  2021-01-18       Impact factor: 84.694

Review 7.  Herpes Simplex Virus Cell Entry Mechanisms: An Update.

Authors:  Krishnaraju Madavaraju; Raghuram Koganti; Ipsita Volety; Tejabhiram Yadavalli; Deepak Shukla
Journal:  Front Cell Infect Microbiol       Date:  2021-01-18       Impact factor: 5.293

8.  Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.

Authors:  Xiao Zhang; Junping Hong; Ling Zhong; Qian Wu; Shanshan Zhang; Qianying Zhu; Haiwen Chen; Dongmei Wei; Rui Li; Wanlin Zhang; Xinyu Zhang; Guosong Wang; Xiang Zhou; Junyu Chen; Yinfeng Kang; Zhenghui Zha; Xiaobing Duan; Yang Huang; Cong Sun; Xiangwei Kong; Yan Zhou; Yanhong Chen; Xiaoping Ye; Qisheng Feng; Shaowei Li; Tong Xiang; Song Gao; Mu-Sheng Zeng; Qingbing Zheng; Yixin Chen; Yi-Xin Zeng; Ningshao Xia; Miao Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-02       Impact factor: 12.779

9.  Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease.

Authors:  Nisha Rathore; Sree Ranjani Ramani; Homer Pantua; Jian Payandeh; Tushar Bhangale; Arthur Wuster; Manav Kapoor; Yonglian Sun; Sharookh B Kapadia; Lino Gonzalez; Ali A Zarrin; Alison Goate; David V Hansen; Timothy W Behrens; Robert R Graham
Journal:  PLoS Genet       Date:  2018-11-02       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.